Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Certara Inc

CERT ✓ COMPLIANT ☆ Track — members

Nasdaq · Technology · Software ·

USA Small Cap Analyst: HOLD

Last Close

$7.94

▼ -2.34%

Market Cap $1.21B · Vol 640.57K

Key Metrics

P/E Ratio

N/A

FWD: 21.20

Market Cap

$1.21B

Small Cap

Div Yield

N/A

EPS Growth

-22.66%

YoY

RSI (14)

48.92

Momentum

Beta

1.45

vs Market

52W High

$13.87

42.75% below

52W Low

$4.45

78.43% above

Volume

640.57K

Avg 1.22M

P/B

1.32

Price-to-book

ROE

6.69%

Return on equity

Free Float

73.44%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Certara Inc (CERT) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CERT pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-4.91%

+1.79%

+41.53%

+8.03%

YTD

-9.88%

-24.95%

-47.14%

-78.98%

Financials & Valuation

TTM · Annual

Total Revenue	$418.84M
Net Income	$-1,595,000.00
Revenue Growth (YoY)	+0.99%
Gross Margin	48.03%
Operating Margin	6.33%
Net Profit Margin	-0.38%
ROE	6.69%
ROA · ROIC	0.49% · -0.42%

P/E Ratio	N/A
Forward P/E (FY1)	21.20
PEG Ratio	N/A
P/S	3.37
P/B	1.32
P/FCF	20.25
EPS Growth	-22.66%
Outstanding Shares	152.54M

Technical Indicators

50-Day SMA	$7.61
200-Day SMA	$7.22
RSI (14)	48.92
Beta	1.45
52-Week High	$13.87
52-Week Low	$4.45

Volume Today	640.57K
Avg Daily Volume (30D)	1.22M
Relative Volume	0.52x
Volatility (10D)	38.95
Volatility (30D)	41.69
Free Float	73.44%

Analyst Consensus

HOLD

Current Price $7.94

Mean Target $8.35

52W Low$4.45 52W High$13.87

Current

Target

$4.45 $13.87

Current Analyst target

+5.16% upside potential · 13 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00Y7BR4L2

ISINUS15687V1098

CountryUnited States of America

Sub-IndustrySoftware (NEC)

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

MSFT Microsoft Corp -2.04% 688256.SS Cambricon Technologies Corp Ltd -2.54% CDNS Cadence Design Systems Inc -3.99% DDOG Datadog Inc -0.85% SNPS Synopsys Inc -5.40%

Company Profile

Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.